Cognetivity Neurosciences (STU:1UB) Market Cap: €0.01 Mil (As of Sep. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cognetivity Neurosciences Market Cap?

Cognetivity Neurosciences STU:1UB Market Cap is €0.01 Mil as of Sep. 07, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cognetivity Neurosciences's share price for the quarter that ended in Oct. 2023 was €0.0695. Cognetivity Neurosciences's Shares Outstanding (EOP) for the quarter that ended in Oct. 2023 was 89.56 Mil. Therefore, Cognetivity Neurosciences's market cap for the quarter that ended in Oct. 2023 was €6.22 Mil.

Cognetivity Neurosciences's quarterly market cap declined from Apr. 2023 (€18.44 Mil) to Jul. 2023 (€8.47 Mil) and declined from Jul. 2023 (€8.47 Mil) to Oct. 2023 (€6.22 Mil).

Cognetivity Neurosciences's annual market cap increased from Jan. 2021 (€25.46 Mil) to Jan. 2022 (€26.84 Mil) but then declined from Jan. 2022 (€26.84 Mil) to Jan. 2023 (€13.48 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cognetivity Neurosciences's Enterprise Value for Today is €0.83 Mil.

Cognetivity Neurosciences  (STU:1UB) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Cognetivity Neurosciences Market Cap Related Terms

Cognetivity Neurosciences Market Cap Historical Data

* Premium members only.

The historical data trend for Cognetivity Neurosciences's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cognetivity Neurosciences Market Cap Chart

Cognetivity Neurosciences Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Market Cap
Get a 7-Day Free Trial 11.50 6.00 25.46 26.84 13.48

Cognetivity Neurosciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.39 13.48 18.44 8.47 6.22

STU:1UB vs VEEV, GEHC, HQY: Market Cap Comparison

For the Health Information Services subindustry, Cognetivity Neurosciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cognetivity Neurosciences Market Cap vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cognetivity Neurosciences's Market Cap distribution charts can be found below:

* The bar in red indicates where Cognetivity Neurosciences's Market Cap falls into.


Cognetivity Neurosciences Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Cognetivity Neurosciences's Market Cap for the fiscal year that ended in Jan. 2023 is calculated as

Market Cap (A: Jan. 2023 )=Share Price (A: Jan. 2023 )*Shares Outstanding (EOP) (A: Jan. 2023 )
=€0.1585*85.049
=€13.48

Cognetivity Neurosciences's Market Cap for the quarter that ended in Oct. 2023 is calculated as

Market Cap (Q: Oct. 2023 )=Share Price (Q: Oct. 2023 )*Shares Outstanding (EOP) (Q: Oct. 2023 )
=€0.0695*89.557
=€6.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of €0.01 Mil mean?
Cognetivity Neurosciences (STU:1UB) has a Market Cap of €0.01 Mil as of Sep. 07, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cognetivity Neurosciences and its competitors.
Is Cognetivity Neurosciences' Market Cap too high?
Cognetivity Neurosciences' current Market Cap is €0.01 Mil.
How does Cognetivity Neurosciences' Market Cap compare to VEEV and GEHC?
Cognetivity Neurosciences' Market Cap of €0.01 Mil can be compared against companies in the Healthcare Providers & Services industry. The industry median Market Cap is 108.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 108.72, based on 691 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cognetivity Neurosciences and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 108.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cognetivity Neurosciences's current Market Cap is €0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cognetivity Neurosciences stock overvalued right now?
Cognetivity Neurosciences (STU:1UB) has a current Market Cap of €0.01 Mil. The current Market Cap is €0.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Cognetivity Neurosciences (STU:1UB), the current Market Cap is €0.01 Mil as of Sep. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cognetivity Neurosciences Business Description

Address 800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.